Evaluating the effect of basic fibroblast growth factor on the progression of NASH disease by inhibiting ceramide synthesis and ER stress-related pathways-Reference-Cited by-同舟云学术

Evaluating the effect of basic fibroblast growth factor on the progression of NASH disease by inhibiting ceramide synthesis and ER stress-related pathways

Published:2023-03 Issue: Volume:942 Page:175536
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Rahimi Shahrzad,Angaji Seyyed Abdolhamid,Majd Ahmad,Hatami Behzad,Baghaei Kaveh^ORCID

Funder

Shahid Beheshti University of Medical Sciences Research Institute for Gastroenterology and Liver Diseases

Publisher

Elsevier BV

Subject

Pharmacology

Reference84 articles.

1. Longitudinal characterization of diet-induced genetic murine models of non-alcoholic steatohepatitis with metabolic, histological, and transcriptomic hallmarks of human patients;Abe;Biology open,2019

2. The burden of non-alcoholic steatohepatitis (NASH) among patients from Europe: a real-world patient-reported outcomes study;Balp;JHEP Rep.,2019

3. Endoplasmic reticulum stress related molecular mechanisms in nonalcoholic steatohepatitis;Bozaykut;Mech. Aging. Develope.,2016

4. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD);Buzzetti;Metabolism,2016

5. Inhibition of endoplasmic reticulum stress is involved in the neuroprotective effect of bFGF in the 6-OHDA-induced Parkinson's disease model;Cai;Aging Dis.,2016

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of key genes and pathways in duck fatty liver syndrome using gene set enrichment analysis;Poultry Science;2024-09

2. Roles and therapeutic targeting of ceramide metabolism in cancer;Molecular Metabolism;2024-05

3. Kiwi-derived extracellular vesicles for oral delivery of sorafenib;European Journal of Pharmaceutical Sciences;2023-12

4. CerS5 deficiency promotes liver fibrosis development in non-alcoholic fatty liver disease;Biochemical and Biophysical Research Communications;2023-07